Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Leiomyomatosis and Renal Cell Carcinoma”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableLooking for participantsNCT04623502
What this trial is testing

An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy

Who this might be right for
Kidney CancerRenal Cell CarcinomaClear Cell Carcinoma+9 more
University of Texas Southwestern Medical Center 600
Testing effectiveness (Phase 2)Study completedNCT00971620
What this trial is testing

Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

Who this might be right for
Cutaneous LeiomyomasHereditary Leiomyomatosis and Renal Cell Cancer
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT01130519
What this trial is testing

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer

Who this might be right for
HLRCCSporadic Papillary Renal Cell Cancer
National Cancer Institute (NCI) 83
Not applicableLooking for participantsNCT00050752
What this trial is testing

Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer

Who this might be right for
Renal Tumor HistologyCutaneous LeiomyomaKidney Cancer
National Cancer Institute (NCI) 1,130
Testing effectiveness (Phase 2)Looking for participantsNCT04981509
What this trial is testing

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

Who this might be right for
Hereditary Leiomyomatosis and Renal Cell CarcinomaPapillary Renal Cell CarcinomaRenal Cell Carcinoma+3 more
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Ended earlyNCT02495103
What this trial is testing

Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaHereditary LeiomyomatosisRenal Cell Cancer
National Cancer Institute (NCI) 7
Early research (Phase 1)Active Not RecruitingNCT04895748
What this trial is testing

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 40
Not applicableLooking for participantsNCT03749980
What this trial is testing

MyVHL: Patient Natural History Study

Who this might be right for
Von Hippel-Lindau DiseaseHereditary Leiomyomatosis and Renal Cell CancerBirt-Hogg-Dube Syndrome+1 more
Joshua Mann, MPH 10,000
Testing effectiveness (Phase 2)WithdrawnNCT04603365
What this trial is testing

Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer

Who this might be right for
Clear Cell Papillary Renal NeoplasmCollecting Duct CarcinomaHereditary Leiomyomatosis and Renal Cell Carcinoma+8 more
Jonsson Comprehensive Cancer Center
Not applicableUnknownNCT05534854
What this trial is testing

Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes

Who this might be right for
Renal Tumor HistologyKidney CancerRenal Cell Carcinoma+11 more
RenJi Hospital 500
Not applicableLooking for participantsNCT00001238
What this trial is testing

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

Who this might be right for
Kidney CancerUrologic Malignant DisordersRenal Cell Carcinoma+2 more
National Cancer Institute (NCI) 5,000